The Role of Cancer-associated Myofibroblasts in Intrahepatic Cholangiocarcinoma

Overview

Journal Nat Rev Gastroenterol Hepatol

Specialty Gastroenterology

Date 2011 Dec 7

PMID 22143274

Citations 97

Authors

Alphonse E Sirica

Affiliations

Soon will be listed here.

Abstract

Intrahepatic cholangiocarcinoma is typically characterized by a dense desmoplastic stroma, of which cancer-associated myofibroblasts (which express α-smooth muscle actin), are a major cellular component. These stromal myofibroblasts have a crucial role in accelerating the progression of intrahepatic cholangiocarcinoma and in promoting resistance to therapy through interactive autocrine and paracrine signaling pathways that promote malignant cell proliferation, migration, invasiveness, apoptosis resistance and/or epithelial-mesenchymal transition. These changes correlate with aggressive tumor behavior. Hypoxic desmoplasia and aberrant Hedgehog signaling between stromal myofibroblastic cells and cholangiocarcinoma cells are also critical modulators of intrahepatic cholangiocarcinoma progression and therapy resistance. A novel strategy has been developed to achieve improved therapeutic outcomes in patients with advanced intrahepatic cholangiocarcinoma, based on targeting of multiple interactive pathways between cancer-associated myofibroblasts and intrahepatic cholangiocarcinoma cells that are associated with disease progression and poor survival. Unique organotypic cell culture and orthotopic rat models of cholangiocarcinoma progression are well suited to the rapid preclinical testing of this potentially paradigm-shifting strategy.

Citing Articles

F-FAPI-42 PET/CT for preoperatively identifying intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

Yang T, Yang Y, Hu S, Xie Y, Shen Z, Zhang Y Quant Imaging Med Surg. 2025; 15(1):741-751.

PMID: 39838999 PMC: 11744148. DOI: 10.21037/qims-24-1489.

The role of mesenchymal cells in cholangiocarcinoma.

Sueca-Comes M, Rusu E, Ashworth J, Collier P, Probert C, Ritchie A Dis Model Mech. 2024; 17(12).

PMID: 39492622 PMC: 11655028. DOI: 10.1242/dmm.050716.

Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest.

Mancarella S, Gigante I, Pizzuto E, Serino G, Terzi A, Dituri F J Exp Clin Cancer Res. 2024; 43(1):286.

PMID: 39415286 PMC: 11484308. DOI: 10.1186/s13046-024-03210-9.

Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma.

Dong Z, Zhang M, Qu L, Zou J, Yang Y, Ma Y Biomark Res. 2024; 12(1):100.

PMID: 39256888 PMC: 11389341. DOI: 10.1186/s40364-024-00648-z.

Role of [F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [F]FDG PET/CT.

Liang J, Jiang S, Song J, Chen D, Weng S, Li S EJNMMI Res. 2024; 14(1):81.

PMID: 39256297 PMC: 11387567. DOI: 10.1186/s13550-024-01145-y.

References

Bornstein P . Matricellular proteins: an overview. J Cell Commun Signal. 2009; 3(3-4):163-5. PMC: 2778588. DOI: 10.1007/s12079-009-0069-z. View

Sirica A, Zhang Z, Lai G, Asano T, Shen X, Ward D . A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines. Hepatology. 2007; 47(4):1178-90. DOI: 10.1002/hep.22088. View

Singh B, Cook K, Martin C, Huang E, Mosalpuria K, Krishnamurthy S . Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer. Clin Exp Metastasis. 2010; 27(4):233-40. DOI: 10.1007/s10585-010-9321-4. View

Nagaharu K, Zhang X, Yoshida T, Katoh D, Hanamura N, Kozuka Y . Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol. 2011; 178(2):754-63. PMC: 3069868. DOI: 10.1016/j.ajpath.2010.10.015. View

Kufe D . Functional targeting of the MUC1 oncogene in human cancers. Cancer Biol Ther. 2009; 8(13):1197-203. PMC: 3035104. DOI: 10.4161/cbt.8.13.8844. View

Sato Y, Harada K, Itatsu K, Ikeda H, Kakuda Y, Shimomura S . Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma. Am J Pathol. 2010; 177(1):141-52. PMC: 2893658. DOI: 10.2353/ajpath.2010.090747. View

Underiner T, Herbertz T, Miknyoczki S . Discovery of small molecule c-Met inhibitors: Evolution and profiles of clinical candidates. Anticancer Agents Med Chem. 2009; 10(1):7-27. DOI: 10.2174/1871520611009010007. View

Sun S, Ning X, Zhang Y, Lu Y, Nie Y, Han S . Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int. 2009; 75(12):1278-1287. DOI: 10.1038/ki.2009.62. View

Miyamoto H, Murakami T, Tsuchida K, Sugino H, Miyake H, Tashiro S . Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas. 2004; 28(1):38-44. DOI: 10.1097/00006676-200401000-00006. View

10.

Omenetti A, Diehl A . Hedgehog signaling in cholangiocytes. Curr Opin Gastroenterol. 2011; 27(3):268-75. PMC: 3636549. DOI: 10.1097/MOG.0b013e32834550b4. View

11.

Nishino R, Honda M, Yamashita T, Takatori H, Minato H, Zen Y . Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J Hepatol. 2008; 49(2):207-16. DOI: 10.1016/j.jhep.2008.03.025. View

12.

Schrader J, Gordon-Walker T, Aucott R, van Deemter M, Quaas A, Walsh S . Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology. 2011; 53(4):1192-205. PMC: 3076070. DOI: 10.1002/hep.24108. View

13.

Edman K, Furber M, Hemsley P, Johansson C, Pairaudeau G, Petersen J . The discovery of MMP7 inhibitors exploiting a novel selectivity trigger. ChemMedChem. 2011; 6(5):769-73. DOI: 10.1002/cmdc.201000550. View

14.

Gillan L, Matei D, Fishman D, Gerbin C, Karlan B, Chang D . Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002; 62(18):5358-64. View

15.

Davaille J, Li L, Mallat A, Lotersztajn S . Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem. 2002; 277(40):37323-30. DOI: 10.1074/jbc.M202798200. View

16.

Aishima S, Taguchi K, Terashi T, Matsuura S, Shimada M, Tsuneyoshi M . Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Mod Pathol. 2003; 16(10):1019-27. DOI: 10.1097/01.MP.0000086860.65672.73. View

17.

Nishihara Y, Aishima S, Hayashi A, Iguchi T, Fujita N, Taketomi A . CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma. Histopathology. 2009; 55(4):423-31. DOI: 10.1111/j.1365-2559.2009.03398.x. View

18.

Tu H, Zhou Z, Liang Q, Li Z, Li D, Qing J . CXCR4 and SDF-1 production are stimulated by hepatocyte growth factor and promote glioma cell invasion. Onkologie. 2009; 32(6):331-6. DOI: 10.1159/000216352. View

19.

Terada T, Okada Y, Nakanuma Y . Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology. 1996; 23(6):1341-4. DOI: 10.1053/jhep.1996.v23.pm0008675149. View

20.

Li G, Li D, Xie Q, Shi Y, Jiang S, Jin Y . RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production. J Gene Med. 2008; 10(9):1039-47. DOI: 10.1002/jgm.1223. View